Jump to main content.

shopping cart


Environmental Assessment of the Proposed Effluent Guidelines for the Pharmaceutical Manufacturing Industry, Vol. I - Final Report

EPA Number: 823R95005
Date of Publication:Febuary, 1995
Audienceconcerned citizens, industry

Available from:
NTIS# PB95-220356Ordering Information
The purpose of this report is to present (1) an assessment of the water quality benefits of controlling the discharge from pharmaceutical manufacturing facilities to surface waters and publicly-owned treatment works (POTWs), and (2) an assessment of the air quality benefits of controlling on-site fugitive emissions to ambient air from open-air wastewater treatment at pharmaceutical manufacturing facilities and volatization of chemical discharges at POTWs. More...

Drug Industry
Water Pollution Control
Economic Impact
Wastewater Treatment
Industrial Waste Treatment
Chemical Effluents
Water Pollution Standards
Water Pollution Economics
Cost Analysis
Pharmaceutical Manufacturing

Jump to main content.